We're sunsetting PodQuest on 2025-07-28. Thank you for your support!
Export Podcast Subscriptions
cover of episode COVIDcast - Tocilizumab [RECOVERY trial]

COVIDcast - Tocilizumab [RECOVERY trial]

2021/2/13
logo of podcast FOAMcast -  An Emergency Medicine Podcast

FOAMcast - An Emergency Medicine Podcast

Shownotes Transcript

Early studies of tocilizumab, a monoclonal antibody that binds interleukin-6 , were disappointing. However, the REMAP-CAP trial) recently reported a benefit to tocilizumab in non-critically ill hospitalized patients with COVID-19. Now, from the RECOVERY trial) (the trial that brought us dexamethasone), we have more good news for tocilizumab - which we cover in this podcast

Show notes: FOAMcast.org)

Thanks for listening! Lauren Westafer and Jeremy Faust